Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
Lectures on the diseases of the nervous system.
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients.
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Protective Effects of PGC-1α via the Mitochondrial Pathway in Rat Brains after Intracerebral Hemorrhage.
No shortcuts to outcome in MS clinical trials?
The influence of nutritional factors on the prognosis of multiple sclerosis.
MRI in multiple sclerosis: current status and future prospects.
One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis.
Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis.
Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.
Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach.
Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the army experience in World War II.
MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.
MRI as an outcome in multiple sclerosis clinical trials.
Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: A longitudinal study.
Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells.
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach.
MRI in multiple sclerosis: what's inside the toolbox?
Gray matter imaging in multiple sclerosis: what have we learned?
Disappearing MS T2 lesions may have persistent tissue injury by diffusion tensor and magnetisation transfer imaging
CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity.
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis.
Gray matter atrophy in multiple sclerosis: a longitudinal study.
Is progressive multiple sclerosis a gray matter disease?